Pfizer Rescues Mylan with Upjohn Merger

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 8 (Table of Contents)

Published: 2 Aug-2019

DOI: 10.3833/pdr.v2019.i8.2446     ISSN: 1756-7874

Section: Mergers & Acquisitions



In a move to narrow the company focus on prescription medicines, Pfizer has agreed to merge its off-patents drug business, Upjohn, with Mylan in a Reverse Morris Trust transaction...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details